Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402896 · ClinicalTrials.gov registry record · Phase 2
Malignant Pleural Effusion With ZD6474
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT00402896: Clinical Trial Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00402896 is a Phase 2 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00402896, a Phase 2 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn the effect of ZD6474 on the amount of time between placement of an indwelling pleural catheter and the catheter's removal in patients with malignant pleural effusion. This study will also look at the effect that ZD6474 has on tumor cells, biological characteristics of cells in the body, rate of fluid build-up around the lungs, tumor size, and thickness of blood vessels. The effect that this drug has on quality of life and shortness of breath will also be examined.
Interventions
- DRUG ZD6474
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00402896
The ClinicalTrials.gov registry entry for NCT00402896 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ZD6474 is the first listed.
NCT00402896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00402896 about?
NCT00402896 is a clinical study titled "Malignant Pleural Effusion With ZD6474". The goal of this clinical research study is to learn the effect of ZD6474 on the amount of time between placement of an indwelling pleural catheter and the catheter's removal in patients with malignant pleural effusion. This study will also look at the effect that ZD6474 has on tumor cells, biologi...
What is the current status of trial NCT00402896?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2006-10. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00402896?
The interventions under investigation include: ZD6474 (DRUG).
Who is sponsoring clinical trial NCT00402896?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.